bioAffinity Technologies

BIAFNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$4.913 M

$2.71 -7.51%

Close of 6 Nov 2026

As of 6 Nov 2026, bioAffinity Technologies (BIAF) has a market capitalization of $4.91M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$6.16M

#3231 by revenue

Earnings

-$14.9M

Loss-making

Shares outstanding

1,820,006

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

bioAffinity Technologies lists more than one class of stock. Company figures above cover all classes combined.

BIAFW

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#8Nrc HealthNRC$538.5M
#9MaxcyteMXCT$135.2M
#10OneMedNetONMD$25.4M
#11bioAffinity TechnologiesBIAF$4.91M
#12iSpecimenISPC$2.00M

What if bioAffinity Technologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$15,574,573

Per share 5,747,075× higher

Bitcoin $1.53T

$842,713.04

Per share 310,964× higher

Apple $5.02T

$2,766,548

Per share 1,020,867× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for bioAffinity Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.